Loading...
XNASSTSSW
Market cap4mUSD
Jan 06, Last price  
0.05USD
1D
59.81%
1Q
29.41%
IPO
-88.21%
Name

Sharps Technology Inc

Chart & Performance

D1W1MN
XNAS:STSSW chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-10m
L
-2,055,516-2,347,162-4,831,158779,885-9,841,638
CFO
-9m
L+32.24%
-1,573,701-1,883,098-3,147,736-6,433,159-8,507,300

Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
URL
https://sharpstechnology.com/
IPO date
Apr 14, 2022
Employees
58
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
11,018
9,393
Unusual Expense (Income)
NOPBT
(11,018)
(9,393)
NOPBT Margin
Operating Taxes
(30)
(5,420)
Tax Rate
NOPAT
(10,988)
(3,974)
Net income
(9,842)
-1,361.93%
780
-116.14%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,030
14,267
BB yield
-148.14%
-145.56%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(3,013)
(4,171)
Cash flow
Cash from operating activities
(8,507)
(6,433)
CAPEX
(698)
(752)
Cash from investing activities
(698)
(3,118)
Cash from financing activities
8,030
12,235
FCF
(10,469)
(8,009)
Balance
Cash
3,013
4,171
Long term investments
Excess cash
3,013
4,171
Stockholders' equity
(24,556)
(15,092)
Invested Capital
32,490
24,733
ROIC
ROCE
EV
Common stock shares outstanding
13,033
8,100
Price
0.42
-65.63%
1.21
 
Market cap
5,420
-44.70%
9,801
 
EV
2,407
5,631
EBITDA
(10,136)
(8,739)
EV/EBITDA
Interest
138
1,320
Interest/NOPBT